Recent advances in tumor-targeting chemotherapy drugs

References

[1] Lyons SK,Trotman LC.Advances in preclinical evaluation of experimental antibody-drug conjugates.Cancer Drug Resist2021;4:745-54

[2] Venkatesh C,Putt KS.Evaluation of the reducing potential of PSMA-containing endosomes by FRET imaging.Cancer Drug Resist2021;4:745-54

[3] Conroy M,Kolch W.Emerging RAS-directed therapies for cancer.Cancer Drug Resist2021;4:543-58

[4] Bijnsdorp IV.Protective autophagy by thymidine causes resistance to rapamycin in colorectal cancer cells in vitro.Cancer Drug Resist2021;4:719-27

[5] Giuliani J,A .Cost-effectiveness of Osimertinib in activating epidermal growth factor receptor gene (EGFR)-mutations in first-line for advanced non-small cell lung cancer.Cancer Drug Resist2021;4:740-44